CB-5339
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CB-5339, covering 2025-09-17 to 2025-09-17. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Safety of CB-5339 in Patients With Cancer [Phase 1]